Need Help?

Comprehensive genomic profiling of matched glioblastoma tumours, cell-lines, and xenografts reveals genomic stability and adaptation to disparate growth environments

The mandate of this project was to use drug screening to deliver new drugs for glioblastoma (GBM) to clinical trials, and perform genomic assessment of GBM to discover new therapeutic targets and predictors of response. The sequencing data in this set was derived from GBM patient tumor samples, matched brain tumor initiating cells lines (BTICs), and tumor tissue derived from orthotopic implants.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001004221 Illumina HiSeq 2000 -
EGAD00001004222 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001004223 Illumina HiSeq 2000 -
EGAD00001004224 Illumina HiSeq 2500 -
EGAD00001004225 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001004226 Illumina HiSeq 2500 -
EGAD00001004227 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004228 Illumina HiSeq 2500 -
EGAD00001004229 Illumina HiSeq 2000 1
EGAD00001004230 Illumina HiSeq 2000 Illumina HiSeq 2500 -
EGAD00001004231 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001004232 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001004233 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004234 Illumina HiSeq 2000 Illumina HiSeq 2500 -
EGAD00001004235 Illumina HiSeq 2000 1
EGAD00001004236 -
EGAD00001004237 Illumina HiSeq 2000 -
EGAD00001004238 Illumina HiSeq 2500 -
EGAD00001004239 Illumina HiSeq 2500 1
EGAD00001004240 Illumina HiSeq 2500 2
EGAD00001004241 Illumina HiSeq 2500 -
EGAD00001004242 Illumina HiSeq 2500 -
EGAD00001004243 Illumina HiSeq 2000 Illumina HiSeq 2500 -
EGAD00001004244 -
EGAD00001004245 Illumina HiSeq 2000 -
EGAD00001004246 Illumina HiSeq 2000 Illumina HiSeq 2500 -
EGAD00001004247 Illumina HiSeq 2500 -
EGAD00001004248 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004249 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004250 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004251 Illumina HiSeq 2000 -
EGAD00001004252 Illumina HiSeq 2000 -
EGAD00001004253 Illumina HiSeq 2000 Illumina HiSeq 2500 3
EGAD00001004254 Illumina HiSeq 2500 1
EGAD00001004255 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004256 Illumina HiSeq 2000 Illumina HiSeq 2500 -
EGAD00001004257 Illumina HiSeq 2000 1
EGAD00001004258 Illumina HiSeq 2000 -
EGAD00001004259 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004260 Illumina HiSeq 2000 Illumina HiSeq 2500 1
EGAD00001004261 Illumina HiSeq 2000 1
EGAD00001004262 Illumina HiSeq 2500 1
EGAD00001004263 Illumina HiSeq 2000 Illumina HiSeq 2500 -
EGAD00001004264 Illumina HiSeq 2500 1
EGAD00001008516 Illumina HiSeq 2500 1
EGAD00001008517 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001008518 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001008519 Illumina HiSeq 2000 1
EGAD00001008520 Illumina HiSeq 2000 1
EGAD00001008521 Illumina HiSeq 2000 1
EGAD00001008522 Illumina HiSeq 2500 1
EGAD00001008523 Illumina HiSeq 2500 1
EGAD00001008524 -
EGAD00001008525 Illumina HiSeq 2000 Illumina HiSeq 2500 2
EGAD00001008526 Illumina HiSeq 2000 Illumina HiSeq 2500 5
EGAD00001008527 Illumina HiSeq 2500 1
EGAD00001008528 -
EGAD00001008529 Illumina HiSeq 2000 Illumina HiSeq 2500 3
EGAD00001008530 Illumina HiSeq 2000 Illumina HiSeq 2500 3
EGAD00001008531 Illumina HiSeq 2500 1
EGAD00001008532 Illumina HiSeq 2000 1
Publications Citations
Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
Proc Natl Acad Sci U S A 116: 2019 19098-19108
24
SLUG Directs the Precursor State of Human Brain Tumor Stem Cells.
Cancers (Basel) 11: 2019 E1635
5
Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
Nat Commun 11: 2020 4997
72